Skip to content

Lipocine Inc.

Public company
Headquarters
SALT LAKE CITY
Ticker
LPCN
CIK
0001535955

WARN notices since 2024

0
None on record

Workers affected since 2024

0
Across 0 notices

Executive changes, last 12 months

2
2 appointments, 0 departures

Last event

Aug 21, 2026
Executive appointmentmember of the Compensation Committee of the Board appointed: Michael Grissinger

Workers affected over time

Cumulative workers in WARN notices since 2024

Not enough notices to chart yet.

Leadership

Role and personSinceChange
member of the Compensation Committee of the BoardMichael GrissingerAug 21, 2026Appointed
directorMichael GrissingerAug 3, 2026Appointed

Same industry and state, with recent events.

  1. Executive appointment

    member of the Compensation Committee of the Board appointed: Michael Grissinger

    Michael Grissinger was named member of the Compensation Committee of the Board of Lipocine Inc., effective August 18, 2026. The company reported the change in an 8-K/A that cites Item 5.02.

    Role: member of the Compensation Committee of the Board

    Source: SEC 8-K, filed Aug 21, 2026
  2. Executive appointment

    director appointed: Michael Grissinger

    Michael Grissinger was named director of Lipocine Inc., effective August 3, 2026. The company reported the change in an 8-K that cites Item 5.02.

    Role: director

    Source: SEC 8-K, filed Aug 3, 2026

Last verified Nov 8, 2026